InflaRx N.V. (IFRX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IFRX SEC filings page.
InflaRx N.V. (IFRX) reported $20K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
The available FY2025 data shows only $20K of revenue, leaving the company’s cash needs, profitability, and financing structure unresolved.
Operating profile remains indeterminate: without net income, operating cash flow, assets, or liabilities alongside revenue, the filing cannot establish whether reported activity reflects a functioning business or an early-stage financial profile.
Evidence is too thin for operating analysis: FY2025 includes a revenue figure but no reported profitability, cash-flow, or balance-sheet measures, so margin, cash-conversion, liquidity, and leverage conclusions would be unsupported.
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
InflaRx N.V. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
InflaRx N.V. generated $20K in revenue in fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
IFRX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F |
|---|---|
| Revenue | $20K |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| InflaRx N.V. IFRX | FY2025 | $20K | N/A | N/A | $235.8M | — |
| Shattuck Labs, Inc. STTK | FY2025 | $1.0M | -$48.8M | N/A | $599.2M | 59/100 |
| Surrozen, Inc. SRZN | FY2025 | $3.5M | -$242.0M | N/A | $349.0M | 42/100 |
| HilleVax, Inc. HLVX | FY2024 | N/A | -$147.3M | N/A | $104.8M | — |
| MacroGenics, Inc. MGNX | FY2025 | $149.5M | -$75K | -0.1% | $238.2M | 57/100 |
| XBiotech Inc XBIT | FY2025 | N/A | -$45.5M | N/A | $69.8M | — |
Where InflaRx N.V. Ranks
Frequently Asked Questions
What is InflaRx N.V.'s annual revenue?
InflaRx N.V. (IFRX) reported $20K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What is InflaRx N.V.'s P/E ratio?
InflaRx N.V. (IFRX) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $235.8M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is InflaRx N.V.'s price-to-sales ratio?
InflaRx N.V. (IFRX) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $20K revenue, FY2025). The market capitalization is $235.8M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.